 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Science
317:1390-1393
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
|
|
Z.Zhou,
J.Zhen,
N.K.Karpowich,
R.M.Goetz,
C.J.Law,
M.E.Reith,
D.N.Wang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Tricyclic antidepressants exert their pharmacological effect-inhibiting the
reuptake of serotonin, norepinephrine, and dopamine-by directly blocking
neurotransmitter transporters (SERT, NET, and DAT, respectively) in the
presynaptic membrane. The drug-binding site and the mechanism of this inhibition
are poorly understood. We determined the crystal structure at 2.9 angstroms of
the bacterial leucine transporter (LeuT), a homolog of SERT, NET, and DAT, in
complex with leucine and the antidepressant desipramine. Desipramine binds at
the inner end of the extracellular cavity of the transporter and is held in
place by a hairpin loop and by a salt bridge. This binding site is separated
from the leucine-binding site by the extracellular gate of the transporter. By
directly locking the gate, desipramine prevents conformational changes and
blocks substrate transport. Mutagenesis experiments on human SERT and DAT
indicate that both the desipramine-binding site and its inhibition mechanism are
probably conserved in the human neurotransmitter transporters.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Structure of the LeuT-desipramine complex and molecular
mechanism of LeuT inhibition by desipramine. (A) Structure shown
as ribbon diagram viewed from within the membrane plane. An
F[obs] – F[calc] map contoured at 3 is superimposed
on the structural model. The EL4 hairpin is colored green, and
the rest of the protein pink. The helices TM6 and TM11 are
removed for clarity. (B) 2F[obs] – F[calc] map contoured at 1
showing the
desipramine-binding site in LeuT, viewed from within the
membrane plane. Residues R30, Y108, and F253 form the
extracellular gate that separates the leucine substrate from the
bound desipramine. (C) Local structural changes of LeuT induced
by desipramine binding. The structure with desipramine bound is
shown in pink and green, without desipramine binding in cyan and
blue. When desipramine binds, the side chain of R30 rotates
toward D404 and forms a salt bridge with the latter, and the EL4
hairpin, along with A319 and F320, is pushed toward to the
extracellular space. (D) Molecular contacts between LeuT and the
bound desipramine molecule. The chemical structure of
desipramine is shown together with LeuT residues that are in
direct contact with the drug. Residues from the EL4 hairpin are
shown in the green box; residues from the rest of the protein
are shown in pink boxes.
|
 |
Figure 3.
Fig. 3. Homology models and electrostatic surface potential of
desipramine-binding sites in human SERT, NET, and DAT. (A)
Desipramine-binding site in the LeuT-desipamine crystal
structure. Homology model and electrostatic surface potential of
desipramine-binding site in (B) hSERT, (C) hNET, and(D) hDAT,
viewed from within the membrane plane. The equivalent residues
of those in LeuT that are in direct contact with desipramine are
indicated.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(2007,
317,
1390-1393)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.W.Ravna,
I.Sylte,
and
S.G.Dahl
(2009).
Structure and localisation of drug binding sites on neurotransmitter transporters.
|
| |
J Mol Model, 15,
1155-1164.
|
 |
|
|
|
|
 |
E.Gouaux
(2009).
Review. The molecular logic of sodium-coupled neurotransmitter transporters.
|
| |
Philos Trans R Soc Lond B Biol Sci, 364,
149-154.
|
 |
|
|
|
|
 |
H.Krishnamurthy,
C.L.Piscitelli,
and
E.Gouaux
(2009).
Unlocking the molecular secrets of sodium-coupled transporters.
|
| |
Nature, 459,
347-355.
|
 |
|
|
|
|
 |
J.Andersen,
A.S.Kristensen,
B.Bang-Andersen,
and
K.Strømgaard
(2009).
Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
|
| |
Chem Commun (Camb), 0,
3677-3692.
|
 |
|
|
|
|
 |
M.Quick,
A.M.Winther,
L.Shi,
P.Nissen,
H.Weinstein,
and
J.A.Javitch
(2009).
Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation.
|
| |
Proc Natl Acad Sci U S A, 106,
5563-5568.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Z.Zhou,
J.Zhen,
N.K.Karpowich,
C.J.Law,
M.E.Reith,
and
D.N.Wang
(2009).
Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.
|
| |
Nat Struct Mol Biol, 16,
652-657.
|
 |
|
|
|
|
 |
A.M.Jørgensen,
and
S.Topiol
(2008).
Driving forces for ligand migration in the leucine transporter.
|
| |
Chem Biol Drug Des, 72,
265-272.
|
 |
|
|
|
|
 |
B.I.Kanner
(2008).
Structural biology: It's not all in the family.
|
| |
Nature, 454,
593-594.
|
 |
|
|
|
|
 |
B.Wenge,
and
H.Bönisch
(2008).
N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.
|
| |
Naunyn Schmiedebergs Arch Pharmacol, 377,
255-265.
|
 |
|
|
|
|
 |
H.Zettl,
M.Schubert-Zsilavecz,
and
C.D.Siebert
(2008).
[The medicinal chemistry of tricyclic antidepressives. Targets and stereochemistry]
|
| |
Pharm Unserer Zeit, 37,
206-213.
|
 |
|
|
|
|
 |
J.Kniazeff,
L.Shi,
C.J.Loland,
J.A.Javitch,
H.Weinstein,
and
U.Gether
(2008).
An intracellular interaction network regulates conformational transitions in the dopamine transporter.
|
| |
J Biol Chem, 283,
17691-17701.
|
 |
|
|
|
|
 |
K.Severinsen,
S.Sinning,
H.K.Müller,
and
O.Wiborg
(2008).
Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site.
|
| |
J Neurochem, 105,
1794-1805.
|
 |
|
|
|
|
 |
L.Celik,
B.Schiøtt,
and
E.Tajkhorshid
(2008).
Substrate binding and formation of an occluded state in the leucine transporter.
|
| |
Biophys J, 94,
1600-1612.
|
 |
|
|
|
|
 |
L.R.Forrest,
Y.W.Zhang,
M.T.Jacobs,
J.Gesmonde,
L.Xie,
B.H.Honig,
and
G.Rudnick
(2008).
Mechanism for alternating access in neurotransmitter transporters.
|
| |
Proc Natl Acad Sci U S A, 105,
10338-10343.
|
 |
|
|
|
|
 |
S.K.Singh,
C.L.Piscitelli,
A.Yamashita,
and
E.Gouaux
(2008).
A competitive inhibitor traps LeuT in an open-to-out conformation.
|
| |
Science, 322,
1655-1661.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Beuming,
J.Kniazeff,
M.L.Bergmann,
L.Shi,
L.Gracia,
K.Raniszewska,
A.H.Newman,
J.A.Javitch,
H.Weinstein,
U.Gether,
and
C.J.Loland
(2008).
The binding sites for cocaine and dopamine in the dopamine transporter overlap.
|
| |
Nat Neurosci, 11,
780-789.
|
 |
|
|
|
|
 |
S.Kitayama,
and
T.Dohi
(2007).
[New development in study of neurotransmitter transporters]
|
| |
Nippon Yakurigaku Zasshi, 130,
443.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|